Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. The company offers Actimab-A, a CD33 targeting radi...
Leadership
Sandesh C. Seth M.B.A., M.S.
CEO, Principal Financial Officer & Chairman
Paul Diamond Esq., Ph.D.
Vice President of Patent & Legal Counsel
Lynn M. Bodarky M.B.A.
Chief Business Officer
Madhuri Vusirikala M.D.
Vice President of Clinical Development BMT & Cellular Therapy
